Flagship Pioneering, Inc

FL96 was founded by Flagship Pioneering, an innovation enterprise that conceives, creates, resources, and builds companies that invent breakthrough technologies to transform health care, agriculture, and sustainability.. Flagship has created over 100 groundbreaking companies since 2000, including Moderna (NASDAQ: MRNA), Generate Biomedicines, Tessera Therapeutics, Indigo Ag, Inari Agriculture, and Sana Biotechnology.. CFA, CPA, or other finance certifications or demonstrable progress toward their completion More About Flagship PioneeringWe are creative optimists, and we would love for you to consider joining our team!. Since its launch in 2000, the firm has applied a unique hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $100 billion in aggregate value.. The current Flagship ecosystem comprises 42 transformative companies, including Denali Therapeutics (NASDAQ: DNLI), Evelo Biosciences (NASDAQ: EVLO), Foghorn Therapeutics (NASDAQ: FHTX), Indigo Ag, Moderna (NASDAQ: MRNA), Omega Therapeutics (NASDAQ: OMGA), Sana Biotechnology (NASDAQ: SANA), and Seres Therapeutics (NASDAQ: MCRB).

finance analyst

Company SummaryFL96, Inc. is a privately held, early-stage company developing a novel AI and data-driven approach to materials discovery and development to accelerate the transition to a sustainable economy.FL96 was founded by Flagship Pioneering, an innovation enterprise that conceives, creates, resources, and builds companies that invent breakthrough technologies to transform health care, agriculture, and sustainability. Flagship has created over 100 groundbreaking companies since 2000, including Moderna (NASDAQ: MRNA), Generate Biomedicines, Tessera Therapeutics, Indigo Ag, Inari Agriculture, and Sana Biotechnology. Responsibilities Work with company leadership to build scenario analysis tools to explore, refine, and explain potential business model innovations for platform companiesPartner with the strategy team to create strategically useful presentations for members of FL96’s leadership teamDirectly interface with related companies in the Flagship ecosystem to explore potential joint opportunities, including how those opportunities might be structured and valuedPartner with Flagship Finance to ensure: alignment across resource requirements, future view of value, and current business strategy and development opportunitiesfinancial reporting is tailored to address the highest priority challenges and help to inform the answers to the most important questions Qualifications Minimum 2 years of investment banking or private equity experienceExperience playing a leading role on projects, prioritizing tasks and meeting deadlinesAbility to represent company interests, including C-suite level presentations, to relevant stakeholdersStrong self-starter and independent thinker with impeccable attention to detailExcellent communication and presentation skills, capable of conveying financial and strategic concepts in a clear and thorough mannerEager to work with highly skilled and dynamic teams in a fast-paced, entrepreneurial setting Preferred Qualifications Experience interfacing with FP&A functions to produce decision-useful information for company leadershipAbility to work with outputs from enterprise-grade information systems (ERP, LIMS, CRM, etc.)CFA, CPA, or other finance certifications or demonstrable progress toward their completion More About Flagship PioneeringWe are creative optimists, and we would love for you to consider joining our team! See all our open opportunities across Flagship Pioneering’s Ecosystem.Flagship Pioneering conceives, creates, resources, and develops first-in-category platform companies to transform human health and sustainability. Since its launch in 2000, the firm has applied a unique hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $100 billion in aggregate value. To date, Flagship has deployed $3.1 billion in capital toward the founding and growth of its pioneering companies alongside more than $19 billion of follow-on investments from other institutions. The current Flagship ecosystem comprises 42 transformative companies, including Denali Therapeutics (NASDAQ: DNLI), Evelo Biosciences (NASDAQ: EVLO), Foghorn Therapeutics (NASDAQ: FHTX), Indigo Ag, Moderna (NASDAQ: MRNA), Omega Therapeutics (NASDAQ: OMGA), Sana Biotechnology (NASDAQ: SANA), and Seres Therapeutics (NASDAQ: MCRB).We believe pioneering is best done by teams, and that it is a process that can be taught, learned, and replicated. Learn more about our Company Creation Model.Can Breakthrough Innovations Be Made Systematically? A Conversation With Noubar Afeyan, Flagship Pioneering’s CEO. Flagship Pioneering and our ecosystem companies are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.Recruitment & Staffing Agencies: Flagship Pioneering and its affiliated Flagship Lab companies (collectively, “FSP”) do not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to FSP or its employees is strictly prohibited unless contacted directly by Flagship Pioneering’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of FSP, and FSP will not owe any referral or other fees with respect thereto.#LI-NM1

START NEW SEARCH